Главная
Рынки
Графики и идеи
Алготрейдинг
Новости
Store
Брокеры
Скачать
Экономический календарь
Торговые сигналы
Вебтерминал
Нажмите
/
для поиска: @user, $symbol, ...
Поиск
Вход
Создать аккаунт
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
URGN
#2067
UroGen Pharma Ltd. Ordinary Shares
21.700
0
+4.28%
Сектор:
Базовая:
Валюта прибыли:
Дневной диапазон
Годовой диапазон
Дневное изменение
+4.28%
Месячное изменение
-0.60%
6-месячное изменение
+14.21%
Годовое изменение
+14.21%
Предыдущее закрытие
20.810
0
Open
21.700
0
Bid
Ask
Low
21.700
0
High
21.700
0
Объем
74
Рынки
Рынок акций США
Здравоохранение
URGN
Open full chart
Financials
Overview
Отчетность
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
42.2 M
46.09 M
46.11 M
46.26 M
46.81 M
—
Valuation ratios
Enterprise value
411.02 M
318.92 M
405.92 M
540.91 M
843.8 M
2.11 B
Price to earnings ratio
3.82
3.6
3.48
4.13
5.76
16.97
Price to sales ratio
4.97
5.05
5.2
6.71
9.83
26.8
Price to cash flow ratio
4.72
4.72
4.49
5.17
6.9
21.28
Price to book ratio
2.6
51.87
4.28
3.69
3.61
63.46
Enterprise value to EBITDA ratio
-4.94
-3.3
-3.76
-4.37
-6.29
-17.73
Profitability ratios
Return on assets %
-0.08
-0.13
-0.18
-0.24
-0.18
-0.73
Return on equity %
-0.93
-4.26
-0.94
-0.53
-0.29
-6.03
Return on invested capital %
-311.73
-364.1
-582.81
-642.29
-348.12
-1 937.33
Gross margin %
90.27
89.94
88.5
85.34
88.07
351.85
Operating margin %
-69.61
-112.59
-182.26
-171.17
-99.65
-565.66
EBITDA margin %
-69.22
-112.74
-182.83
-172
-100.68
-568.25
Net margin %
-93.93
-152.71
-216.47
-206.24
-121.34
-696.75
Liquidity ratios
Quick ratio
8.77
5.81
5.47
3.99
3.79
19.06
Current ratio
9
6.01
5.65
4.14
3.99
19.79
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.09
0.08
0.08
0.11
0.14
0.41
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.4
0.43
0.49
0.59
0.66
2.17
Long term debt to total equity ratio
4.77
-13.83
-2.63
-1.31
-1.06
-18.83
Per share metrics
Operating cash flow per share
-0.64
-0.29
-0.89
-0.83
-0.88
-2.89
EBIT per share
-0.41
-0.59
-0.78
-0.87
-0.58
-2.82
EBITDA per share
-0.4
-0.59
-0.78
-0.87
-0.58
-2.82
Total debt per share
—
—
—
—
—
—
Cash per share
5.9
5.14
4.23
3.39
2.65
15.4
Net current asset value per share
6.85
5.87
5
4.12
3.51
18.5
Tangible book value per share
0.59
-0.19
-0.98
-1.96
-2.4
-5.52
Working capital per share
6.09
4.89
4.12
3.13
2.63
14.77
Book value per share
0.59
-0.19
-0.98
-1.96
-2.4
-5.52
Новости
UroGen Pharma: CMO Schoenberg verkauft Aktien im Wert von 145.000 US-Dollar
UroGen Pharma CMO Schoenberg sells $145k in shares
enGene Holdings: A Potential Oncology Entrant (NASDAQ:ENGN)
2025 Performance Review And Future Strategy
Urogen Pharma-Aktie erreicht 52-Wochen-Hoch bei 25,2 USD
Urogen Pharma Ltd stock hits 52-week high at 25.2 USD
UroGen Pharma at Guggenheim Conference: Strategic Insights into UGN-102 Launch
Urogen Pharma stock hits 52-week high at 23.66 USD
UroGen Pharma Ltd. (URGN) Q3 2025 Earnings Call Transcript
Positive Studiendaten beflügeln Aktie von UroGen Pharma
UroGen Pharma stock jumps after positive Phase 3 trial results
UroGen Pharma stock price target raised to $30 from $25 at D. Boral Capital